UPLOAD Filing
CollPlant Biotechnologies Ltd
Date: April 1, 2026 · CIK: 0001631487 · Accession: 0000000000-26-003285
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294738
Letter
April 1, 2026 Yehiel Tal Chief Executive Officer CollPlant Biotechnologies Ltd. 4 Oppenheimer, Weizmann Science Park Rehovot 7670104, Israel Re:CollPlant Biotechnologies Ltd. Registration Statement on Form F-1 Filed March 30, 2026 File No. 333-294738 Dear Yehiel Tal: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Mark S. Selinger, Esq.
Show Raw Text
April 1, 2026
Yehiel Tal
Chief Executive Officer
CollPlant Biotechnologies Ltd.
4 Oppenheimer, Weizmann Science Park
Rehovot 7670104, Israel
Re:CollPlant Biotechnologies Ltd.
Registration Statement on Form F-1
Filed March 30, 2026
File No. 333-294738
Dear Yehiel Tal:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Conlon Danberg at 202-551-4466 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and Services
cc:Mark S. Selinger, Esq.